FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial

Clinical trial NCT06244004 · RECRUITING

Trial details

NCT number: NCT06244004
Sponsor: Northwestern University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Castration-Sensitive Prostate Carcinoma Metastatic Prostate Carcinoma Stage IVB Prostate Cancer AJCC v8

Start date: 2024-02-18
Primary completion: 2027-02-18
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.